How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model

Ahmed, 1984, Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: role of the H-2 region in determining crossreactivity for different lymphocytic choriomeningitis virus strains, J. Virol., 51, 34, 10.1128/JVI.51.1.34-41.1984

Allouche, 1982, Limit-dilution analysis of weak influenza-immune T cell responses associated with H-2Kb and H-2Db, J. Immunol., 129, 689, 10.4049/jimmunol.129.2.689

Baekkeskov, 1990, Human diabetes, Curr. Topics Microbiol. Immunol., 164, 125

Borrow, 1991, Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection, J. Exp. Med., 174, 203, 10.1084/jem.174.1.203

Buchmeier, 1981, Monoclonal antibodies to lymphocytic choriomeningitis viruses: generation, characterization and cross-reactivity with other arenaviruses, Virology, 113, 73, 10.1016/0042-6822(81)90137-9

Cooke, 1990, Role of CD4+ cells in diabetes (IDDM), Curr. Topics Microbiol. Immunol., 164, 125

de la Torre, 1992, Selective disruption of growth hormone transcription machinery by viral infection, 89, 9939

Dutko, 1983, Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains, J. Gen. Virol., 64, 1689, 10.1099/0022-1317-64-8-1689

Dyrberg, 1990, The role of viruses and the immune system in diabetes mellitus: experimental models, Curr. Topics Microbic]. Immunol., 156, 1

Eisenbarth, 1986, Type 1 diabetes mellitus: a chronic autoimmune disease, N. Engl. J. Med., 314, 1360, 10.1056/NEJM198605223142106

Fung-Leung, 1991, Immune response against LCMV infection in mice without CD8+ expression, J. Exp. Med., 174, 1425, 10.1084/jem.174.6.1425

Hanahan, 1985, Heritable formation of pancreatic β-cell tumors in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes, Nature, 315, 115, 10.1038/315115a0

Heath, 1992, Autoimmune diabetes as a consequence of locally produced interleukin-2, Nature, 359, 547, 10.1038/359547a0

Heath, 1993, Avidity for antigen can influence the helper dependence of CD8+ T lymphocytes, J. Immunol., 151, 5993, 10.4049/jimmunol.151.11.5993

Hogan, 1986

Jenson, 1984, Multiple viruses in diabetes mellitus, Prog. Med. Virol., 29, 197

Klavinskis, 1989, Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection, J. Virol., 63, 4311, 10.1128/JVI.63.10.4311-4316.1989

Kosaka, 1993, Tolerance of CD8+ T cells developing in parent F, chimeras prepared with supralethal irradiation: step-wise induction of tolerance in the intrathymic and extrathymic environments, J. Exp. Med., 177, 367, 10.1084/jem.177.2.367

Laufer, 1993, Autoimmune diabetes can be induced in transgenic MHC class II deficient mice, J. Exp. Med., 178, 589, 10.1084/jem.178.2.589

Lewicki, 1990, Generation and use of CTL clones, 99

Maniatis, 1982

Miller, 1993, The role of the thymus in immunity: thirty years of progress, Immunologist, 1, 9

Muller, 1992, LCMV-specific class II restricted CTL in β2M-deficient mice, Science, 255, 1576, 10.1126/science.1347959

Notkins, 1984, Virus-induced diabetes mellitus, 241

Ohashi, 1991, Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice, Cell, 65, 305, 10.1016/0092-8674(91)90164-T

Oldstone, 1987, Molecular mimicry and autoimmune disease, Cell, 50, 819, 10.1016/0092-8674(87)90507-1

Oldstone, 1988, Prevention of type I diabetes in nonobese mice by virus infection, Science, 239, 500, 10.1126/science.3277269

Oldstone, 1982, Restricted expression of viral glycoprotein in cells of persistently infected mice, Nature, 300, 360, 10.1038/300360a0

Oldstone, 1988, Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virusspecific class I-restricted H-2Db cytotoxic T lymphocytes, J. Exp. Med., 168, 559, 10.1084/jem.168.2.559

Oldstone, 1991, Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response, Cell, 65, 319, 10.1016/0092-8674(91)90165-U

Pircher, 1991, Lower receptor avidity required for thymic clonal deletion than for effector T-cell function, Nature, 351, 482, 10.1038/351482a0

Ramsdell, 1990, Clone[ deletion versus clonal anergy, Science, 248, 1342, 10.1126/science.1972593

Salvato, 1988, Virus-lymphocyte interactions. IV. Molecular charecterization of LCMV Armstrong (CTL+) and that of its variant, Clone 13 (CTL), Virology, 164, 517, 10.1016/0042-6822(88)90566-1

Southern, 1987, Molecular characterization of the genome S RNA segment from lymphocytic choriomeningitis virus, Virology, 157, 145, 10.1016/0042-6822(87)90323-0

Sprent, 1990, T-cell reactivity to MHC molecules: immunity versus tolerance, Science, 248, 1357, 10.1126/science.1694041

Tishon, 1988, Viruslymphocyte interactions. II. Expression of viral sequences during the course of persistent lymphocytic choriomeningitis virus infection and their localization to the L3T4 lymphocyte subset, J. Immunol., 140, 1280, 10.4049/jimmunol.140.4.1280

Todd, 1988, A molecular basis for MHC-associated autoimmunity, Science, 240, 1003, 10.1126/science.3368786

Unger, 1985, Diabetes mellitus, 1018

Whitton, 1988, Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus, Virology, 162, 321, 10.1016/0042-6822(88)90471-0

Whitton, 1988, Molecular definition of a major cytotoxic T lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus, J. Virol., 62, 687, 10.1128/JVI.62.3.687-695.1988

Whitton, 1989, Molecular analyses of a five amino acid cytotoxic T lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity, J. Virol., 63, 4303, 10.1128/JVI.63.10.4303-4310.1989

Yanagi, 1992, Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule, J. Virol., 66, 2527, 10.1128/JVI.66.4.2527-2531.1992